MRKR (Marker Therapeutics) FFO


MRKR Marker Therapeutics Inc MRKR
32 GF Score
Price $1.32
! 1 Warning Sign
View Full Analysis

What is Marker Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

MRKR
32GF Score
Marker Therapeutics Inc MRKR
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Marker Therapeutics Business Description

Other Exchanges GX1:Germany
Address 2450 Holcombe Boulevard, TMC Partners Office 1.311, Houston, TX, USA, 77021
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).
32GF Score

Get the complete analysis for MRKR

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.32
Price